A study looking at treatment for high risk neuroblastoma (HR/NBL2/SIOPEN)

This study is looking at chemotherapy, radiotherapy and stem cell transplants for people with high risk neuroblastoma.

It is open to children and young people with a high risk neuroblastoma that:

• is newly diagnosed, and

• you are about to start chemotherapy

Please note, we use the term ‘you’ in this summary, but of course if you are a parent of a child with cancer, we are referring to your child.